NR3C2 and Alzheimer disease: In particular, NDP-α-MSH interaction with melanocortin receptor 4 (MC4R) (16), the most abundant MCR in the CNS and the only one present in microglia and astrocytes, has been already shown as an effective treatment for ischemia and early and moderate AD in experimental mouse models (10, 17–22).